Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05770037
Status:
RECRUITING
Last Update Posted:
2024-01-05
First Post:
2022-11-24
Brief Title:
DETERMINE Trial Treatment Arm 01 Alectinib in Adult TeenageYoung Adults TYA and Paediatric Patients With ALK Positive Cancers
Sponsor:
Cancer Research UK
Organization:
Cancer Research UK
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neuroblastoma |
| Solid Tumor |
| Haematological Malignancy |
| Malignant Neoplasm |
| Lymphoproliferative Disorders |
| Neoplasms by Histologic Type |
| Neoplasms by Site |
| Cancer |
| Anaplastic Large Cell Lymphoma |
| Lymphoma |
| Renal Cell Carcinoma |
Keywords:
| Name | View |
|---|---|
| Adult | View |
| Alectinib | View |
| ALK Tyrosine Kinase Receptor | View |
| Antineoplastic Agents | View |
| Cancer | View |
| Child | View |
| Malignancy | View |
| Malignant Neoplasms | View |
| Molecular Targeted Therapy | View |
| Mutation | View |
| Neoplasms by Histologic Site | View |
| Neoplasms by Site | View |
| Paediatric | View |
| Precision Medicine | View |
| Protein Kinase Inhibitors | View |
| Rare | View |
| Tumour-agnostic | View |
| Young adult | View |